The Institute “Dr. Simo Milošević” in Igalo, Montenegro, is witnessing a resurgence in interest from Norwegian healthcare sectors, signaling a potential revival of its once-thriving medical tourism. This development comes as the Institute emerges from recent financial difficulties and seeks to re-establish itself as a key player in Europe’s specialized rehabilitation market.
Historically, the Institute has catered to Norwegian patients, particularly those with rheumatic diseases, since 1976. This partnership was supported by a state-funded program that provided high-quality rehabilitation services at lower costs than those available in Norway. The influx of Norwegian patients has been crucial for the Institute, generating annual revenues between €2.7 million and €3 million, which accounted for about 25% of its total income.
However, recent years have seen this vital revenue stream disrupted due to operational instability and governance issues that resulted in losing the Norwegian contract. Consequently, many patients were redirected to competing destinations like Turkey, leading to a significant drop in predictable income and increased reliance on domestic demand.
In response to these challenges, the Institute has undergone a transformation since 2025-2026, transitioning from near-bankruptcy to stabilization. This shift is supported by a government-backed restructuring plan valued at approximately €88 million aimed at modernizing facilities and upgrading medical equipment.
Financial indicators suggest positive changes, with the Institute reporting profits and improved liquidity after years of losses while maintaining service provision and workforce stability. The restructuring also includes recapitalization efforts from both government and private shareholders, alongside debt resolution strategies.
The renewed signals from Norway are strategically significant as the Norwegian healthcare system relies on periodic tenders for sending patients abroad for rehabilitation services. The next procurement cycle is anticipated in 2026 for the period of 2027-2030, presenting an opportunity for Igalo to re-enter this lucrative market.
Re-engagement with Norway would not only restore a critical revenue source but also position Igalo within a stable segment of the European healthcare market characterized by longer patient stays and direct public-sector financing. This contrasts sharply with traditional tourism flows that are often seasonal and price-sensitive.
From an economic perspective, attracting Norwegian patients aligns with Montenegro’s broader strategy to enhance its tourism sector by focusing on higher-value activities such as health tourism. This approach aims to extend the tourist season and improve overall revenue per visitor.
The Institute is well-equipped for this transition due to its combination of medical facilities and natural therapeutic resources like mineral waters and medicinal mud. This unique blend supports its long-standing thalassotherapy model, distinguishing it within the regional market.
However, regaining international competitiveness will require careful execution of its restructuring plan, which focuses on capital investment and quality improvements. Upgrading accommodation units, renewing medical equipment, and retaining specialized staff are essential steps to meet international standards necessary for successful tender bids.
The dynamics of labor are particularly critical as the Institute’s competitive edge has historically relied on a highly skilled workforce in physical medicine and rehabilitation. Retaining this talent will be vital as European healthcare providers increasingly compete for skilled personnel.
Moreover, Norway’s approach to healthcare outsourcing reflects broader European trends toward cross-border medical services driven by cost efficiency and capacity limitations within domestic systems. For smaller economies like Montenegro, this presents an opportunity to position specialized facilities as nearshore healthcare providers for Western European markets.
However, competition remains fierce with countries like Turkey and Spain enhancing their offerings through modern infrastructure and competitive pricing strategies. To successfully re-enter the Norwegian system, Igalo must not only leverage its historical credibility but also demonstrate significant improvements in quality and reliability.
A renewed contract with Norway would provide multi-year revenue visibility and bolster further investments while enhancing the Institute’s reputation across European healthcare networks. It would also signify Montenegro’s capability to deliver institutional-grade services aligned with Western European standards—an essential message for attracting broader investment flows.
The timing of these developments is crucial as Montenegro progresses toward EU accession, where sectors like healthcare are increasingly expected to meet European standards in quality and governance. The transformation of Igalo into a competitive international rehabilitation center aligns directly with this narrative.
This situation underscores a structural shift in Montenegro’s economic model away from mass tourism toward specialized segments such as luxury real estate and medical services. Each segment caters to different demand profiles that are less reliant on seasonal fluctuations and more aligned with sustainable capital flows.
The renewed interest from Norway signifies not just a sector-specific development but also reflects Montenegro’s repositioning within European service value chains—moving away from volume-driven tourism toward integrated higher-value offerings.
Ultimately, the upcoming tender cycle will determine whether Igalo can successfully transition from recovery to reintegration into the Norwegian healthcare system. Current signals suggest that the Institute is once again being recognized as a credible partner—an outcome that seemed uncertain just a few years ago.
